Latest stories on KLRA
Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026 | KLRA Stock News
StockTitan67 · bullishproduct/pr
Kailera Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference | KLRA Stock News
StockTitan50 · neutralgeneral
Kailera Reports First Quarter 2026 Financial Results and Provides Clinical Data Updates | KLRA Stock News
StockTitan53 · neutralearnings
This Weight-Loss Drug Challenger Could Follow Eli Lilly's Playbook: Analyst
Yahoo Top58 · neutralanalyst